The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Open accessAbstract
Abnormalities in CD4+CD25+Foxp3+ regulatory T (T reg) cells have been implicated in susceptibility to allergic, autoimmune, and immunoinflammatory conditions. However, phenotypic and functional assessment of human T reg cells has been hampered by difficulty in distinguishing between CD25-expressing activated and regulatory T cells. Here, we show that expression of CD127, the α chain of the interleukin-7 receptor, allows an unambiguous flow cytometry–based distinction to be made between CD127lo T reg cells and CD127hi conventional T cells within the CD25+CD45RO+RA− effector/memory and CD45RA+RO− naive compartments in peripheral blood and lymph node. In healthy volunteers, peripheral blood CD25+CD127lo cells comprised 6.35 ± 0.26% of CD4+ T cells, of which 2.05 ± 0.14% expressed the naive subset marker CD45RA. Expression of FoxP3 protein and the CD127lo phenotype were highly correlated within the CD4+CD25+ population. Moreover, both effector/memory and naive CD25+CD127lo cells manifested suppressive activity in vitro, whereas CD25+CD127hi cells did not. Cell surface expression of CD127 therefore allows accurate estimation of T reg cell numbers and isolation of pure populations for in vitro studies and should contribute to our understanding of regulatory abnormalities in immunopathic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In terms of surface phenotype, the best accepted combination of markers is high expression of the IL-2 receptor α chain (CD25) and low expression of the IL-7R α chain (CD127) [134, 385].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [385]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakaguchi, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,315
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher‐Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,889
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. D. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
von Freeden-Jeffry, U., Vieira, P., Lucian, L., McNeil, T., Burdach, S. E. G., & Murray, R. (1995) · Journal of Experimental Medicine · doi:10.1084/jem.181.4.1519 · Cited by 1,648
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,253
Ling, E. M., Smith, T. R. F., Nguyen, X. D., Pridgeon, C., Dallman, M. J., Arbery, J., Carr, V. A., & Robinson, D. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15592-x · Cited by 759
Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo
Gavin, M. A., Clarke, S. R. M., Negrou, E., Gallegos, A. M., & Rudensky, A. Y. (2001) · Nature Immunology · doi:10.1038/ni743 · Cited by 643
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level
Roncador, G., Brown, P. J., Maestre, L., Hüe, S., Martinez-Torrecuadrada, J. L., Ling, K., Pratap, S., Toms, C., Fox, B. C., Cerundolo, V., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526189 · Cited by 592
Flagged first, then by citations
Research works printed but not linked: 1
- 2005, Hum. Immunol., 66, 13
Cited by
Sorted by citations
Items 701–800 of 1,000
An In Vivo IL-7 Requirement for Peripheral Foxp3+ Regulatory T Cell Homeostasis
Kim, G., Ligons, D. L., Hong, C., Luckey, M. A., Keller, H. R., Tai, X., Lucas, P. J., Gress, R. E., & Park, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102328 · Cited by 33
“Foxp3 directly suppresses IL-7Ra transcription and thus could lower IL-7 sensitivity (13, 14).”
Natural Tregs and autoimmunity
Cava, A. L. (2009) · Frontiers in bioscience · doi:10.2741/3247 · Cited by 31
Lee, C., Lin, S., Cheng, P., & Kuo, M. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2008.00843.x · Cited by 32
“CD127 (the IL-7 receptor a chain) expression may be tested to better discriminate Treg cells from conventional T cells as it has been reported that Treg cells may have significantly lower CD127 expression (24).”
BackgroundRegulatory T Cells and IL-17-Producing Cells in Graft-Versus-Host Disease
Teshima, T., Maeda, Y., & Ozaki, K. (2011) · Immunotherapy · doi:10.2217/imt.11.51 · Cited by 32
Revisiting regulatory T cells in type 1 diabetes
Zhang, Y., Bandala‐Sanchez, E., & Harrison, L. C. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328355a2d5 · Cited by 32
“receptor alpha chain [39,40] and expression of the Ikaros transcription factor family member Helios [41].”
BackgroundImmune tolerance and control of CNS autoimmunity: from animal models to MS patients
Cassan, C., & Liblau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04270.x · Cited by 32
Landskron, J., & Taskén, K. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.04.008 · Cited by 31
Strömbeck, A., Rabe, H., Lundell, A., Andersson, K., Johansen, S., Adlerberth, I., Wold, A. E., Hesselmar, B., & Rudin, A. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12290 · Cited by 31
CD4+CD25+regulatory T cells in systemic sclerosis and other rheumatic diseases
Amelsfort, J. M. R. M.-V., Walter, G. J., & Taams, L. S. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.28 · Cited by 31
Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis
Pagel, J., Hartz, A., Figge, J., Gille, C., Eschweiler, S., Petersen, K., Schreiter, L., Hammer, J., Karsten, C. M., Friedrich, D., et al. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12810 · Cited by 31
Regulatory T Cells Show Dynamic Behavior During Late Pregnancy, Delivery, and the Postpartum Period
de Lima, J. J. A. V., Martins, C. G., Nunes, G., de Sousa, M. J. R., Branco, J. C., & Borrego, L. M. (2016) · Reproductive Sciences · doi:10.1177/1933719116676395 · Cited by 31
Abramovitch, J. B., Lopata, A. L., O’Hehir, R. E., & Rolland, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173549 · Cited by 32
Luo, L., Zeng, X., Huang, Z., Luo, S., Qin, L., & Li, S. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00619-7 · Cited by 31
Zuber, J., Viguier, M. A., Lemaı̂tre, F., Senée, V., Patey, N., Elain, G., Geissmann, F., Fakhouri, F., Ferradini, L., Julier, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.034 · Cited by 31
Seissler, N., Schmitt, E., Hug, F., Sommerer, C., Zeier, M. G., Schaier, M., & Steinborn, A. (2012) · Transplant Immunology · doi:10.1016/j.trim.2012.09.003 · Cited by 31
In vitro-expanded CD4+CD25highFoxp3+ regulatory T cells controls corneal allograft rejection
Guo, X., Jie, Y., Ren, D., Zeng, H., Zhang, Y., He, Y., & Pan, Z. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.08.014 · Cited by 31
Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma
Bruneau, J., Canioni, D., Renand, A., Marafioti, T., Paterson, J. C., Martin‐Garcia, N., Gaulard, P., Delfau‐Larue, M., Hermine, O., Macintyre, E. A., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100150 · Cited by 31
“15 CD127 weak expression was considered to be a preferred alternative for identification of Treg.16,17 In a multiparametric FC approach, we gated Treg on CD4 , CD25hi, FOXP3 , CD127low expression, and AITL cells on CD4 and CD10 expression (see supplemental Figure S1 at http://ajp.amjpathol.org).”
InfluentialZhao, S.-S., Hu, J.-W., Wang, J., Lou, X.-J., & Zhou, L.-L. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900543 · Cited by 31
Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside
Olivieri, J., Coluzzi, S., Attolico, I., & Olivieri, A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/924954 · Cited by 32
“These cells were first identified as bearing high levels of the membrane-bound IL-2Ra (CD25), while subsequent refinement included the expression of the transcriptional regulator FoxP3 and lack of the IL7-Ra chain (CD127) as additional molecular markers [25, 26].”
BackgroundBlache, C. A., Lequerré, T., Roucheux, A., Beutheu, S., Dedreux, I., Jacquot, S., Loët, X. L., Boyer, O., & Vittecoq, O. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker183 · Cited by 31
Liu, Q., An, L., Qi, Z., Zhao, Y., & Li, C. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12612 · Cited by 31
Immune regulation and anti-cancer activity by lipid inflammatory mediators
Khadge, S., Sharp, J. G., McGuire, T. R., Thiele, G. M., Black, P. N., Dirusso, C., Cook, L. M., Klassen, L. W., & Talmadge, J. E. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.026 · Cited by 32
Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression
Clark, G. J., Rao, M., Ju, X., & Hart, D. N. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107035 · Cited by 31
“The absence of CD127 on CD4 T lymphocytes has been correlated with Treg cells [23, 24], but CD127 cells were present in all the populations we defined by the level of CMRF-35 epitope expression.”
BackgroundHaque, R., Lei, F., Xiong, X., Wu, Y., & Song, J. J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2983 · Cited by 30
Paasela, M., Kolho, K., Vaarala, O., & Honkanen, J. K. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001998 · Cited by 30
“83 %ofCD4 þ cellswasusedasT eff(24,25) .”
Krausz, L. T., Fischer‐Fodor, E., Major, Z. Z., & Fetică, B. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500108 · Cited by 30
Rouas, R., Merimi, M., Najar, M., Zein, N. E., Fayyad‐Kazan, M., Berehab, M., Agha, D. M., Bron, D., Burny, A., Rachidi, W., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28367 · Cited by 32
“Recent reports have shown that the combination of low surface expression of CD127 (the α‐chain of the IL‐7 receptor) with high CD25 expression allows distinguishing between human regulatory and conventional T cells in the thymus, cord blood, adult peripheral blood (PB), and lymph nodes (Hartigan‐O’Connor, Poon, Sincla…”
BackgroundThe making and function of CAR cells
Zabel, M., Tauber, P. A., & Pickl, W. F. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.06.002 · Cited by 30
Transcriptional regulation of Treg homeostasis and functional specification
Wang, K., & Fu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03534-7 · Cited by 34
Regulatory T Cells in the Tumor Microenvironment
Dadey, R., Workman, C. J., & Vignali, D. A. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_6 · Cited by 32
Donor reactive regulatory T cells
Feng, G., Chan, T., Wood, K. J., & Bushell, A. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832c58f1 · Cited by 30
Isolation, propagation and characterization of cord blood derived CD4+ CD25+ regulatory T cells
Bresatz, S., Sadlon, T., Millard, D., Zola, H., & Barry, S. C. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.06.006 · Cited by 30
The effect of aging on T-regulatory cell frequency in HIV infection
Tenorio, A. R., Spritzler, J., Martinson, J., Gichinga, C. N., Pollard, R. B., Lederman, M. M., Kalayjian, R. C., & LANDAY, A. L. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.10.001 · Cited by 30
Self-citationRegulatory T cells as potential immunotherapy in allergy
Wing, K., & Sakaguchi, S. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000246625.79988.12 · Cited by 30
Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance
Mougiakakos, D. (2011) · Cancers · doi:10.3390/cancers3021708 · Cited by 30
“Ligands for CCR4 (e.g., CCL17 and/or CCL22) were in contrast to IL-6 and TGF-β not highly expressed in the tumor tissue, altogether indicating a conversion from CD8 + Tconvs rather than a tumor directed migration as the cause for the observed infiltration.”
BackgroundInfluentialMesquita, D., Cruvinel, W. D. M., Araújo, J. A. P., Pucci, F. V. C., Salmazi, K. C., Kallás, E., & Andrade, L. E. C. (2010) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2010.489229 · Cited by 30
“Alternative putatively reliable surface phenotypes for Treg cells include CD25+CD127low/Ø, CD25+CD45RA+, and CD4+CD39+ (5, 6, 35, 36).”
BackgroundMethodAssociation of two clones allows for optimal detection of human FOXP3
Presicce, P., Moreno‐Fernandez, M. E., Lages, C. S., Orsborn, K. I., & Chougnet, C. A. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20875 · Cited by 29
“Anti-CD127 (R34.”
InfluentialThe FOXP3+ subset of human CD4+CD8+ thymocytes is immature and subject to intrathymic selection
Tuovinen, H., Pekkarinen, P. T., Rossi, L. H., Mattila, I. P., & Arstila, T. P. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.36 · Cited by 30
Cutting Edge: Human CD4−CD8− Thymocytes Express FOXP3 in the Absence of a TCR
Tuovinen, H., Kekäläinen, E., Rossi, L. H., Puntila, J., & Arstila, T. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3651 · Cited by 30
Zlamy, M., Almanzar, G., Parson, W., Schmidt, C., Leierer, J., Weinberger, B., Jeller, V., Unsinn, K., Eyrich, M., Würzner, R., et al. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0058-z · Cited by 29
“On separated subsets of human peripheral CD8+ T cells, almost 100 % of naive (CD45RA + CCR7+) and central memory (CD45R0 + CCR7+) T cells and 60–70 % of effector memory (CD45R0 + CCR7-), but only <20 % of terminally differentiated (CD45RA + CCR7-) T cells express CD127 [50–52] which agrees with our results.”
ResultJedema, I., van de Meent, M., Pots, J. M., Kester, M. G. D., van der Beek, M. T., & Falkenburg, J. H. F. (2011) · Haematologica · doi:10.3324/haematol.2010.039099 · Cited by 29
Oh, J. S., Kim, Y., Lee, S., So, M. W., Choi, S. W., Lee, C., & Yoo, B. (2012) · Rheumatology International · doi:10.1007/s00296-012-2365-9 · Cited by 29
Saison, J., Demaret, J., Venet, F., Chidiac, C., Malcus, C., Poitevin‐Later, F., Tardy, J., Ferry, T., & Monneret, G. (2012) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21047 · Cited by 29
“A good correlation between these two phenotypes was reported in healthy subjects (13) and in septic patients (14).”
BackgroundJordakieva, G., & Jensen‐Jarolim, E. (2018) · World Allergy Organization Journal · doi:10.1186/s40413-018-0197-0 · Cited by 29
“Circulating Treg numbers did not differ between healthy subjects and in AR outside of allergen exposure [32], with an increase of Treg cells in nasal mucosa after allergen challenge and during allergen season [33, 34].”
BackgroundChinn, I. K., Milner, J. D., Scheinberg, P., Douek, D. C., & Markert, M. L. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12088 · Cited by 29
Taylor, A. L., Cross, E. L. A., & Llewelyn, M. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03529.x · Cited by 29
Caro, V. D., D’Anneo, A., Phillips, B. E., Engman, C., Harnaha, J., Lakomy, R., Styche, A. J., Trucco, M., & Giannoukakis, N. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04334.x · Cited by 29
Panfilis, G. D., Campanini, N., Santini, M., Mori, G., Tognetti, E., Maestri, R., Lombardi, M., Froio, E., Ferrari, D., & Ricci, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701046 · Cited by 30
“, 2005; Banham, 2006); moreover, FOXP3þ cells may show regulatory activity irrespective of their CD25 expression (Banham, 2006; Liu et al., 2006; Seddiki et al., 2006).”
BackgroundLiu, Y., Chen, Y., Lamb, J. R., & Tam, P. K. H. (2007) · Transplantation · doi:10.1097/01.tp.0000289990.55668.0d · Cited by 29
“The studies highlight the importance of Foxp3 and reduced CD127 expression as Treg cell markers that function independently of CD25 expression (19, 20).”
BackgroundKataoka, H., Yasuda, S., Fukaya, S., Oku, K., Horita, T., Atsumi, T., & Koike, T. (2014) · Modern Rheumatology · doi:10.3109/14397595.2014.899736 · Cited by 29
Peters, J. H., Koenen, H. J. P. M., Fasse, E., Tijssen, H. J., IJzermans, J. N. M., Groenen, P. J. T. A., Schaap, N. P., Kwekkeboom, J., & Joosten, I. (2013) · Blood · doi:10.1182/blood-2013-03-489443 · Cited by 29
“Human naive and memory CD4 T cells express the IL-7 receptor (CD127), while in contrast, this receptor is lacking on human CD4CD25 Tregs.(45,46) The absence of CD127 expression might explain the lack of a4b1 on Tregs.”
BackgroundBaatjes, A. J., Smith, S. G., WATSON, R. M., Howie, K. J., Murphy, D. M., Larché, M., Denburg, J. A., Inman, M. D., & O’Byrne, P. M. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12594 · Cited by 29
Li, C.-R., Deiro, M. F., Godebu, E., & Bradley, L. M. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.06.002 · Cited by 28
“Although ex vivo expanded nTreg cells can control autoimmune responses in the NOD model with remarkable success [5, 39], it is impossible to unequivocally isolate cells with regulatory function from human peripheral blood on the basis of the currently used markers, high levels of CD25 combined with low levels of IL-7R…”
BackgroundPolyclonal Expansion of Human CD4+CD25+ Regulatory T Cells
Hoffmann, P., Eder, R., & Edinger, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_2 · Cited by 29
Lifshitz, G. V., Zhdanov, D. D., Lokhonina, А. V., Eliseeva, D. D., Lyssuk, E. Y., Завалишин, И. А., & Быковская, С. Н. (2016) · Autoimmunity · doi:10.1080/08916934.2016.1199020 · Cited by 29
“Tregs express low levels of the IL-7 receptor (CD127) at their cell surface [12,13].”
BackgroundMiyara, M., Chader, D., Burlion, A., Goldstein, J. D., Sterlin, D., Norol, F., Trebeden‐Negre, H., Claër, L., Sakaguchi, S., Marodon, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10914 · Cited by 29
“Other groups have focused on CD4+CD25+CD127low/- cells because this phenotypic definition indeed encompasses all FOXP3 expressing CD4+ T cells [31, 32].”
Fitas, A. L., Martins, C. G., Borrego, L. M., Lopes, L., Jörns, A., Lenzen, S., & Limbert, C. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12671 · Cited by 29
“5 (clone SK3, Biolegend) and anti-CD127 AlexaFluor647 (clone A019D5, Biolegend) (Additional information in Figure S1, Supporting Information).(21,22) 964 FITAS ET AL.”
Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis
Langdon, K., & Haleagrahara, N. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1465943 · Cited by 30
Sageshima, J., Ciancio, G., Guerra, G., Gaynor, J. J., Cova, D., Zarak, A., Chen, L., Mattiazzi, A. D., Kupin, W. L., Roth, D., et al. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.07.002 · Cited by 29
Combined T regulatory cell and Th2 expression profile identifies children with cow's milk allergy
Savilahti, E. M., Karinen, S., Salo, H. M., Klemetti, P., Saarinen, K. M., Klemola, T., Kuitunen, M., Hautaniemi, S., Savilahti, E., & Vaarala, O. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.02.011 · Cited by 29
Monti, P., Brigatti, C., Heninger, A., Scirpoli, M., & Bonifacio, E. E. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02825.x · Cited by 29
“In resting T cells, CD25 was mainly confined to a small subset of CD4+ T cells which did not express CD127, consistent with a regulatory T-cell phenotype (14,15).”
BackgroundBinayke, A., Zaheer, A., Vishwakarma, S., Singh, S., Sharma, P., Chandwaskar, R., Gosain, M., Raghavan, S., Murugesan, D. R., Kshetrapal, P., et al. (2024) · npj Vaccines · doi:10.1038/s41541-023-00794-9 · Cited by 28
High content cellular immune profiling reveals differences between rhesus monkeys and men
Magalhaes, I., Vudattu, N. K., Ahmed, R. K. S., Kühlmann‐Berenzon, S., Ngo, Y., Sizemore, D. R., Wehlin, L., Weichold, F., Andersson, J., Skeiky, Y. A. W., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03284.x · Cited by 28
Phetsouphanh, C., Xu, Y., & Zaunders, J. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00681 · Cited by 27
“that the IL7Rα (CD127) is expressed at low to intermediate levels on the surface of Tregs and the combination of CD25+ CD127lo can be used to distinguish Treg from other CD4 subsets; CD25+ CD127low Tregs contain high amounts of Foxp3 and can suppress immune responses in vitro (51, 52).”
BackgroundInfluentialSelf-citationChera, M., Hamel, Y., Baillou, C., Touil, S., Guillot‐Delost, M., Charlotte, F., Kossir, L., Simonin, G., Maury, S., Cohen, J. L., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x683566 · Cited by 28
“For these reasons, the development of specific cell-based therapies may offer alternative approaches to prevent and/or to control severe GVHD. Natural regulatory T cells (Tregs) are defined by constitutive expression of high levels of the transcription factor forkhead box P3 (FOXP3), which is critical for their develo…”
BackgroundInfluentialSchmidt, A., Rieger, C. C., Venigalla, R. K., Éliás, S., Max, R., Lorenz, H., Gröne, H., Krammer, P. H., & Kuhn, A. (2017) · Immunologic Research · doi:10.1007/s12026-017-8904-4 · Cited by 29
“Although expression of FOXP3 simultaneously with a high-level expression of CD25 identifies a largely pure Treg population, additional markers have been suggested to assure even better exclusion of activated conventional T cells, such as absence of CD49d [5] or CD127 [6] on Tregs; however, the latter does not enable d…”
BackgroundLandwehr-Kenzel, S., Zobel, A., Hoffmann, H., Landwehr, N., Schmueck‐Henneresse, M., Schachtner, T., Roemhild, A., & Reinke, P. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.021 · Cited by 28
Waickman, A. T., Keller, H. R., Kim, T., Luckey, M. A., Tai, X., Hong, C., Molina-Parı́s, C., Walsh, S. T. R., & Park, J. (2020) · iScience · doi:10.1016/j.isci.2020.101421 · Cited by 28
“Here, we considered that Foxp3+ Treg cells are uniquely low in IL-7Ra expression compared with conventional CD4 T cells (Figure 2A) (Seddiki et al., 2006; Liu et al., 2006; Cozzo et al., 2003).”
BackgroundResultInfluentialSasson, S. C., Zaunders, J., Nahar, K. J., Munier, C. M. L., Fairfax, B. P., Olsson-Brown, A. C., Jolly, C., Read, S. A., Ahlenstiel, G., Palendira, U., et al. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13502 · Cited by 27
Self-citationNovel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis
Adriawan, I. R., Atschekzei, F., Dittrich‐Breiholz, O., Garantziotis, P., Hirsch, S., Risser, L. M., Kosanke, M., Schmidt, R. E., Witte, T., & Sogkas, G. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220955 · Cited by 28
Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment
Hadjiaggelidou, C., & Katodritou, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194588 · Cited by 28
Bremm, M., Huenecke, S., Lehrnbecher, T., Ponstingl, E., Mueller, R., Heinze, A., Bug, G., Quaiser, A., Kapinsky, M., Brehm, C., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.07.018 · Cited by 28
Rabe, H., Lundell, A., Andersson, K., Adlerberth, I., Wold, A. E., & Rudin, A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0511244 · Cited by 28
“Staining for CD25 and CD127 to identify Tregs [38] and study their expression of CTLA-4 in infants could have been a better approach.”
BackgroundRegulatory T cells: balancing protection versus pathology
Rakebrandt, N., Lambert, K., & Joller, N. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14343 · Cited by 30
Michaëlsson, J., Barbosa, H. M. R., Jordan, K. A., Chapman, J. M., Brunialti, M. K. C., Neto, W. K., Nukui, Y., Sabino, É. C., Chieia, M. A. T., Oliveira, A. S. B., et al. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-41 · Cited by 28
“In addition, it was recently demonstrated that TReg cells are characterized by low levels of the IL-7Rα (CD127low) [40-42], which together with CD25 help to distinguish TReg cells from activated normal CD4+ T cells in healthy individuals.”
BackgroundElrefaei, M., Burke, C. M., Baker, C. A. R., Jones, N. G., Bousheri, S., Bangsberg, D. R., & Cao, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008194 · Cited by 28
“The lack of CD127 expression on FOXP3 positive CD4+ T cells is used to distinguish between regulatory and effector T cells [48,49].”
Mota, C., Silva, V. M. D. S., Pires, A. R., Matoso, P., Victorino, R. M. M., Sousa, A. E., & Caramalho, Í. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400198 · Cited by 27
“from the starting populations (25, 26) (Supplemental Fig.”
BackgroundHoerning, A., Wilde, B., Wang, J., Tebbe, B., Jing, L., Wang, X., Jian, F., Zhu, J.-Q., Dolff, S., Kribben, A., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000273 · Cited by 27
Kerstan, A., Albert, C., Klein, D., Bröcker, E., & Trautmann, A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.025 · Cited by 28
Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity
Wright, G. P., Ehrenstein, M. R., & Stauss, H. J. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.96 · Cited by 27
Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression
Donnelly, C., Dykstra, B. J., Mondal, N., Huang, J., Kaskow, B. J., Griffin, R. L., Sackstein, R., & Baecher‐Allan, C. (2018) · Scientific Reports · doi:10.1038/s41598-017-17981-z · Cited by 28
Diverse functions and mechanisms of regulatory T cell in ischemic stroke
Wu, Y., Li, J., Shou, J., Zhang, W., & Chen, C. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113782 · Cited by 26
OMIP ‐024: Pan‐leukocyte immunophenotypic characterization of PBMC subsets in human samples
Moncunill, G., Han, H., Dobaño, C., McElrath, M. J., & Rosa, S. C. D. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22580 · Cited by 28
Current understanding of HIV-1 and T-cell adaptive immunity: Progress to date
Mohan, T., Bhatnagar, S., Gupta, D. L., & Rao, D. N. (2014) · Microbial Pathogenesis · doi:10.1016/j.micpath.2014.06.003 · Cited by 29
Jin, Y., Chen, X., Podolsky, R. H., Hopkins, D., Makala, L., Muir, A., & She, J. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.10.005 · Cited by 27
Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow Transplantation
DAVIES, J. K., Nadler, L. M., & Guinan, E. C. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000153 · Cited by 27
Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia
Mpakou, V., Ioannidou, H.-D., Konsta, E., Vikentiou, M., Spathis, A., Kontsioti, F., Kontos, C. K., Velentzas, A. D., Papageorgiou, S. G., Vasilatou, D., et al. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.07.004 · Cited by 27
Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
Goonetilleke, N. P., Clutton, G., Swanstrom, R., & Joseph, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01966 · Cited by 27
Lanzilli, G., Traggiai, E., Braido, F., Garelli, V., Folli, C., Chiappori, A., Riccio, A., Bazurro, G., Agazzi, A., Magnani, A., et al. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.11.009 · Cited by 27
Regulatory T cells: hypes and limitations
Șchiopu, A., & Wood, K. J. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283061137 · Cited by 27
Thornton, C. A. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110001886 · Cited by 28
McLoughlin, R. M., Calatroni, A., Visness, C. M., Wallace, P. K., Cruikshank, W. W., Tuzova, M. N., Ly, N. P., Ruiz‐Perez, B., Kattan, M., Bloomberg, G. R., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03882.x · Cited by 27
CD4+CD25-FoxP3+T cells: a distinct subset or a heterogeneous population?
Zohouri, M., Mehdipour, F., Razmkhah, M., Faghih, Z., & Ghaderi, A. A. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1797005 · Cited by 26
“naïve CD4þCD25– T cells transiently express CD25, but unlike Tregs they show high CD127 expression.(13)”
BackgroundRegulatory T cells in inflammation and resolution of acute lung injury
Wang, L., Jiang, W., Wang, X., Tong, L., & Song, Y. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13527 · Cited by 25
Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?
D'Arena, G. F., Simeon, V., D’Auria, F., Statuto, T., Sanzo, P. D., Martino, L. D., Marandino, A., Sangiorgio, M., Musto, P., & Feo, V. D. (2013) · Europe PMC (PubMed Central) · Cited by 26
Regulatory cells and cell signatures in clinical transplantation tolerance
Newell, K. A., Phippard, D., & Turka, L. A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.008 · Cited by 26
“These limitations have been somewhat overcome by the demonstration that CD127, the alpha chain of the IL-7 receptor, when used in conjunction with IL-25 expression effectively distinguishes Foxp3+ Teff from Foxp3+ Treg with functional Treg confined to the CD25+CD127 population [23,24].”
BackgroundGuillot‐Delost, M., Cheraï, M., Hamel, Y., Rosenzwajg, M., Baillou, C., Simonin, G., Leclercq, V., Mariotti‐Ferrandiz, E., Six, A., Bon‐Durand, V., et al. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1220 · Cited by 26
“As shown in Figure 3B, MACS-sorted CD25+ cells cultured in the presence of rapamycin remained CD127low/− and CD25high at day-21, whereas CD4+CD25− cells cultured under the same conditions acquired CD25 and remained CD127+.”
BackgroundInfluentialInfluence of CD4+/CD25+regulatory T cells on atherogenesis in patients with end-stage kidney disease
Meier, P., Meier, R., & Blanc, E. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.7.987 · Cited by 26
PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20
Nicholson, I., Mavrangelos, C., Bird, D. R. G., Bresatz, S., Eastaff‐Leung, N., Grose, R., Gundsambuu, B., Hill, D. L., Millard, D. J., Sadlon, T. J., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.04.002 · Cited by 26
Impaired function of regulatory T cells in cord blood of children of allergic mothers
Hrdý, J., Kocourková, I., & Prokešová, L. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04630.x · Cited by 26
Metadata
- Authors
- Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., Kelleher, A., & de St. Groth, B. F.
- Affiliations
- The University of Sydney (AU)
- 4Department of Paediatrics, University of Sydney, Western Clinical School, Penrith, NSW 2751, Australia
- Rush University Medical Center (US)
- St Vincent's Hospital Sydney (AU)
- Royal Prince Alfred Hospital (AU)
- Children's Hospital at Westmead (AU)
- UNSW Sydney (AU)
- 1Centenary Institute of Cancer Medicine and Cell Biology, Faculty of Medicine, University of Sydney, Newtown, NSW 2042, Australia
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-07-03
- Volume
- 203
- Issue
- 7
- Pages
- 1693-1700
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118333
- OpenAlex
- W2168628806
- Cited by
- 1,512
- References
- 30
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 32 · 2023: 32 · 2022: 44 · 2021: 49 · 2020: 58 · 2019: 75 · 2018: 51 · 2017: 64 · 2016: 74 · 2015: 63 · 2014: 87 · 2013: 92 · 2012: 116
- FWCI
- 45.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Funders
- Crohn's and Colitis Foundation of America
- Crohn's and Colitis Foundation
- Medical Research Council
- National Health and Medical Research Council
- National Institute of Allergy and Infectious Diseases (P01AI055793, AI55793, U19AI055793)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- regulatory T cells, CD127, interleukin-2 receptor, Foxp3, CD25, CD4+ T cells, naive T cells, effector memory T cells
- MeSH terms
- Adult, Humans, Infant, Newborn, Lymphocyte Activation, Receptors, Interleukin-2, T-Lymphocyte Subsets, Receptors, Interleukin-7, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review